Accendra Health Inc (ACH)

Accendra Health Inc. is a healthcare company listed on the NYSE under the ticker ACH. Through its subsidiaries, the company provides healthcare solutions in the United States, with operations centered on in-home care and delivery support for diabetes treatment, home respiratory therapy, and obstructive sleep apnea care. Its respiratory offerings include home oxygen and non-invasive ventilation services, along with continuous positive airway pressure and bi-level positive airway pressure devices and related patient support services. Accendra Health also supplies other home medical equipment and patient care product lines, including ostomy, wound care and negative pressure wound therapy, urology, and incontinence-related products and services. The company serves patients and home health agencies. Formerly known as Owens & Minor, Inc., it adopted the Accendra Health name in December 2025 and is based in Glen Allen, Virginia.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-ACH
$1.14
27.8% Upside
Undervalued
$1.51
69.7% Upside
Bargain
Fair
0.0%
November 4, 2026
68.422 M
1.891 B
95.8%
73.5%
0.8
323.0%
Valuation • Fair Value

Accendra Health Inc (NYSE-ACH) Fair Value by Valuation Model

Review the available estimates for Accendra Health Inc (NYSE-ACH), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$1.14

Estimated upside of 27.8% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.46

Discounted cash flow valuation reference.

Comps Fair Value

$1.36

Comparable-company valuation reference.

Analyst Price Target

$1.51

Analysts imply upside of 69.7%.

How to read these valuation models

Use the 5 available valuation references for Accendra Health Inc (NYSE-ACH) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Accendra Health Inc (NYSE-ACH)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

2.647 B

Current operating scale indicator.

Revenue Forecast

2.491 B

Forward revenue estimate.

EBITDA

288.2 M

Current operating profitability reference.

EBITDA Forecast

304.5 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Accendra Health Inc (NYSE-ACH) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Accendra Health Inc (NYSE-ACH)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.30

No elevated caution signal from this screen.

Altman Z-Score

0.8

Lower score that deserves closer risk review.

FCF / Net Income

323.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Accendra Health Inc (NYSE-ACH). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Accendra Health Inc (NYSE-ACH)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 4, 2026

Days to Earnings

47

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Accendra Health Inc (NYSE-ACH), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Accendra Health Inc (NYSE-ACH) Stock Forecast & Technical Outlook

Review Accendra Health Inc (NYSE-ACH) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Accendra Health Inc (NYSE-ACH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Accendra Health Inc (NYSE-ACH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Accendra Health Inc (NYSE-ACH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Accendra Health Inc (NYSE-ACH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Accendra Health Inc (NYSE-ACH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Accendra Health Inc (NYSE-ACH)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Accendra Health Inc (NYSE-ACH) has a Hold consensus, with 0 buy, 4 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 4
Sell 0
FAQ Fast Investor Answers

Accendra Health Inc (NYSE-ACH) Stock FAQ

Data-supported answers about Accendra Health Inc (NYSE-ACH), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.14
Estimated upside 27.8%
Valuation Rating
Undervalued
Estimated upside of 27.8%
Analyst Target
$1.51
Implied upside 69.7%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Accendra Health Inc (NYSE-ACH) is $1.14. This implies an estimated upside of 27.8% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 27.8% versus the current market price.

The available analyst price target for Accendra Health Inc (NYSE-ACH) is $1.51. The analyst target implies estimated upside of 69.7%.

The current financial health read for Accendra Health Inc (NYSE-ACH) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Accendra Health Inc (NYSE-ACH) is November 4, 2026.

The latest available data indicates no current dividend yield for Accendra Health Inc (NYSE-ACH).

The current market capitalization listed for Accendra Health Inc is 68.422 M.

The current enterprise value listed for Accendra Health Inc is 1.891 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Accendra Health Inc is NYSE-ACH, and the stock is listed on NYSE.

Accendra Health Inc (NYSE-ACH) is listed on NYSE.

The current debt-to-total-capital ratio listed for Accendra Health Inc is 95.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Accendra Health Inc is 73.5%. Free float helps investors understand how much of the share base is available for public trading.